Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 8Hematopoietic and Lymphatic System Neoplasm 7Neoplasms 5Lung Neoplasms 5Malignant Solid Neoplasm 4Colorectal Neoplasms 4Prostatic Neoplasms 3Ovarian Neoplasms 3Hematologic Neoplasms 3Thyroid Cancer, Papillary 2Oropharyngeal Neoplasms 2Multiple Myeloma 2Mouth Neoplasms 2Melanoma 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2Head and Neck Neoplasms 2Depression 2Colonic Neoplasms 2Carcinoma 2Anatomic Stage I Breast Cancer AJCC v8 2Advanced Malignant Solid Neoplasm 2Adenocarcinoma, Follicular 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Testicular Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Spondylitis, Ankylosing 1Smoking Cessation 1Sarcoma 1

Interventions

Standard of Care 1Interviews as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
ACT-GEN × Interviews as Topic × 90 days × Clear all
NCT07565467 2026-05-04

ACT-GEN (Adherence And Care Tracking In GENetic Cancer Syndromes)

M.D. Anderson Cancer Center

Phase NA Not yet recruiting
80 enrolled

ACT-GEN

Data powered by HemOnc (CC BY 4.0) Colophon âš¡